http://ift.tt/eA8V8J
TEL AVIV, Israel, May 25, 2017 /PRNewswire/ — BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, today reports its financial results for the first quarter ended March 31, 2017.
Highlights and achievements during the…
May 25, 2017 at 04:34PM
from
No comments:
Post a Comment